Lv1
50 积分 2024-03-30 加入
FcRn Inhibitor Therapies in Neurologic Diseases
16天前
已完结
Clinical Outcomes and Identification of Patients With Persistent Penumbral Profiles Beyond 24 Hours From Last Known Well: Analysis From DEFUSE 3
18天前
已完结
DEFUSE 3 study
18天前
已关闭
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
18天前
已完结
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
3个月前
已关闭
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
3个月前
已完结
Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
3个月前
已完结
Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
3个月前
已完结
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China
3个月前
已关闭
Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
4个月前
已完结
皖公网安备34019202002308
